![Malte Peters](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Malte Peters
Amministratore Delegato presso
TANGO THERAPEUTICS, INC.
Patrimonio netto: 256 950 $ in data 31/08/2026
Profilo
Malte Peters is currently Chief Executive Officer & Director at HOOKIPA Pharma, Inc. since 2024.
Since 2018, holds the positions of President, Chief Executive Officer & Director at Tango Therapeutics, Inc., Director at Tango Therapeutics Sub, Inc., Director-Cancer Research at Merck KGAA Unsponsored ADR Facility, and Research Scientist at Amgen NV.
Formerly Chief Executive Officer & Director at Hookipa Biotech AG in 2024.
Served as Director-Cancer Research at Merck KGaA from 2003 to 2004 and Medical Director at Micromet AG during the same period.
From 2004 to 2015, was Head-Clinical, Site Head-Basel & East Hanover at Novartis AG.
From 2015 to 2017, was Global Head-Clinical Development at Sandoz International GmbH.
From 2020 to 2022, was Chief Research & Development Officer at MorphoSys AG.
Education includes a doctorate from Freie Universität Berlin.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/04/2026 | 11.250 ( 0,01% ) | 256 950 $ | 31/08/2026 |
Posizioni attive di Malte Peters
| Società | Posizione | Inizio |
|---|---|---|
| TANGO THERAPEUTICS, INC. | Amministratore Delegato | 08/01/2026 |
| HOOA PHARPAR | Amministratore Delegato | 22/07/2024 |
Tango Therapeutics Sub, Inc.
 Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops transformational new drugs for cancer patients | Direttore/Membro del Consiglio | 10/10/2018 |
Amgen NV
 Amgen NV Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for patients with serious illness | Corporate Officer/Principal | - |
Merck KGAA Unsponsored ADR Facility | Corporate Officer/Principal | - |
Precedenti posizioni note di Malte Peters
| Società | Posizione | Fine |
|---|---|---|
Hookipa Biotech AG
 Hookipa Biotech AG Medical SpecialtiesHealth Technology Develops new generation prophylactic and therapeutic vaccines | Amministratore Delegato | 18/11/2024 |
| MORPHOSYS AG | Direttore Tecnico/Scientifico/R&S | 01/10/2022 |
Sandoz International GmbH
 Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Corporate Officer/Principal | 01/02/2017 |
| NOVARTIS AG | Direttore Tecnico/Scientifico/R&S | 01/05/2015 |
| ░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Malte Peters
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
80
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Merck KGAA Unsponsored ADR Facility | |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
Micromet AG
 Micromet AG Pharmaceuticals: MajorHealth Technology Manufactures and markets drugs | Health Technology |
Sandoz International GmbH
Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals | Health Technology |
Freie Universität Berlin
 Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amgen NV
Amgen NV Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for patients with serious illness | Health Technology |
Hookipa Biotech AG
Hookipa Biotech AG Medical SpecialtiesHealth Technology Develops new generation prophylactic and therapeutic vaccines | Health Technology |
Tango Therapeutics Sub, Inc.
Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Develops transformational new drugs for cancer patients | Health Technology |
HOOKIPA Pharma, Inc.
 HOOKIPA Pharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company which develops pharmaceutical products for immunotherapeutics targeting infectious diseases and cancers | Health Technology |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
